NCT07136558View on ClinicalTrials.gov

Evaluation of ICP-B794 in Patients With Advanced Solid Tumors

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

410

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

June 30, 2029

Study Completion Date

December 31, 2030

Conditions
Advanced Solid Tumors
Interventions
DRUG

ICP-B794

Intravenous administration once every 3 weeks

Trial Locations (1)

510000

Guangdong Provincial People's Hospital, Guangzhou

All Listed Sponsors
lead

Beijing InnoCare Pharma Tech Co., Ltd.

INDUSTRY